OBSadvanced

Describe the three primary life cycle stages targeted by malaria vaccine strategies and explain two major biological barriers that complicate malaria vaccine development.

Answer

The three primary life cycle stages targeted by malaria vaccines are: (1) Pre-erythrocytic stage (targeting sporozoites and liver stages to prevent infection of red blood cells), (2) Erythrocytic or blood stage (targeting merozoites and infected red blood cells to lessen clinical illness and parasitemia), and (3) Sexual or transmission-blocking stage (targeting gametocytes or mosquito-stage antigens to prevent parasite transmission to mosquitoes). Two major biological barriers to vaccine development are extensive antigenic variation (genetic diversity across parasite strains and life stages) and complex immune evasion mechanisms that hinder the development of durable protective immunity.

Explanation

The lecture presents vaccine development as challenging because malaria involves multiple parasite stages and variable antigens, while protective immunity is complex. It also reports historical trial outcomes, including variable SPf66 efficacy; these should be understood as lecture content rather than assumed to represent current vaccine recommendations. **Key takeaway:** A malaria vaccine must address biological complexity and practical research barriers.\n\n**Glossary:** **Antigenic variation**: changes in parasite antigens that can evade immune recognition; **transmission-blocking**: intended to interrupt parasite passage through mosquitoes.

Related Questions

Want to practice more questions like this?

Join myBenkio free and practice past questions for your Nigerian university courses with AI explanations for every answer.

Start Practicing Free